WHO ICTRP trial

A comparison of the effect of meal replacements (FastFX and Optifast) on weight…

ACTRN12620000643976 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting

Key facts

Trial ID ACTRN12620000643976
Public title A comparison of the effect of meal replacements (FastFX and Optifast) on weight loss prior to Intragastric Balloon Insertion
Scientific title Effect of FastFX vs Optifast for Low Energy Meal Replacement on weight prior to Intragastric Balloon Insertion: A Randomised Doubled Blinded Trial.
Primary sponsor The Macmurray Gastroenterology and Endoscopy Center
Secondary sponsors HealthFX
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Recruiting
Study type Interventional
Phase Not Applicable
Countries New Zealand
Conditions Obesity; Obesity;Diet and Nutrition - Obesity
Interventions The intervention is FastFX meal replacement, taken for 2 weeks, instead of the current standard of Optifast. Following randomisation, patients will receive from the dietician 2 week’s worth of meal replacement in single-serve plain snap…
Registration date Mar 6, 2020
Target size 56
Secondary IDs Nil
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations